Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-128.08%
↑ 94% vs avg
Percentile
P70
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-2111.80%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -128.08% | +90.3% |
| 2024 | -1325.26% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | -100.0% |
| 2021 | 19.23% | +100.4% |
| 2020 | -4633.22% | -26.4% |
| 2019 | -3664.86% | +24.8% |
| 2018 | -4870.34% | -65.9% |
| 2017 | -2935.39% | +18.0% |
| 2016 | -3580.08% | - |